Bayer supports pharmaceutical research project

Bayer says that its Bayer HealthCare subsidiary and Leiden University (Leiden, Netherlands) will coordinate a newly founded international consortium, called kinetics for drug discovery (K4DD), which has been launched to explore a novel concept in drug discovery and to tackle a problem in the development of new drugs. Although successful in early phases of development, many drug candidates fail in clinical studies due to lack of efficacy, Bayer says. The new five-year project will focus on ‘optimizing binding kinetics’ for drug candidates with the goal...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers